2 Top Small-Cap Stocks to Buy Right Now
Doubt has seized investors around the world. Economists are still determining the likely effects of the coronavirus pandemic on growth, employment, and industries ranging from auto insurance to animal health. That all suggests now is not a great time to invest in riskier assets, but investors with a long-term mindset might be able to step just outside their comfort zones given the circumstances.
Take development-stage drug companies as one example. They're inherently risky in normal times, let alone when a pandemic is bringing many clinical trials to a halt. But the market volatility of the last month or so has reduced stock prices without much discrimination. That means even the most promising early-stage companies are trading at relatively attractive prices.
If investors are willing to stomach a little more risk and buy small-cap stocks, then they might want to take a closer look at Axsome Therapeutics (NASDAQ: AXSM) and Dicerna Pharmaceuticals (NASDAQ: DRNA).
Source Fool.com
